B of A Securities analyst Heather Bellini upgrades Dun & Bradstreet Hldgs (NYSE:DNB) from Underperform to Neutral and raises the price target from $16 to $17.
Artelo Biosciences Announces Publication Of New Peer-Reviewed Research Demonstrating Protective Properties Of ART27.13 Against Muscle Degeneration Caused By Certain Cancers
Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological
